Case Study: National Consultation on HER2 Testing
The task
- Our client asked us to help achieve maximum adoption of HER2 status testing in all breast cancer patients nationwide
Our solution
- Harness the gravitas of expert opinion to create a consensus authoritative enough to be accepted as a best practice guideline
- Create 'The National Consultation of Prospective HER2 Testing' as a virtual forum driven by email, to open debate, fashion opinion and ultimately review practice
The results
- 235 breast oncologists and pathologists signed up to the testing process – far exceeding the target of 100
- 99% agreement was attained that all women diagnosed with breast cancer should be tested for HER2 status directly post-surgery
Going beyond
- Finalist in Communiqué awards 2006
- Target for participation exceeded by 250%
- Mike Richards, National Cancer Director, endorsed the initiative
- Client verdict: 'An excellent initiative, which overachieved against expectations'
